Abnormalities of the cingulate gyrus in bipolar disorder and other severe psychiatric illness: Postmortem findings from the Stanley Foundation Neuropathology Consortium and literature review

Clinical Neuroscience Research

Volumn 2, Issue 3-4, 2002, Pages 171-181

  Knable, Michael B ^a   Barci, Beata M ^a   Bartko, John J ^a   Webster, Maree J ^b   Fuller Torrey, E ^a,b  

^a Stanley Medical Research Institute   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cingulate gyrus; Manic depression; Neuropathology; Postmortem; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; CALBINDIN; NEUROMODULIN; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; RNA; SEROTONIN UPTAKE INHIBITOR; SYNAPTOPHYSIN;

ANALYSIS OF VARIANCE; AUTOPSY; BIPOLAR DISORDER; BRAIN REGION; CELL DENSITY; CINGULATE GYRUS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DRUG TARGETING; GENE THERAPY; GLIA CELL; HUMAN; HUMAN TISSUE; LIMBIC CORTEX; MAJOR DEPRESSION; MEDICAL LITERATURE; MENTAL DISEASE; PATHOLOGICAL ANATOMY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SCHIZOPHRENIA; STATISTICAL ANALYSIS;

EID: 0036891128     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(02)00042-7     Document Type: Review

References (99)

1. Aganova EA, Uranova NA. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol 1992;22(1):59-65.
2. Andreasen N, Rezai K, Alliger R, et al. Hypofrontality in neuroleptic naïve patients and in patients with chronic schizophrenia. Arch Gen Psychiatry 1992;49:943-958.
3. Artiges E, Salame P, Recasens C, et al. Working memory control in patients with schizophrenia: a PET study during a random number generation task. Am J Psychiatry 2000;157:1517-1519.
4. Ashton L, Barnes A, Livingston M, Wyper D. Cingulate abnormalities associated with PANSS negative scores in first episode schizophrenia. Behav Neurol 2000;12:93-101.
5. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000;47:305-313.
6. Beauregard M, Leroux J-M, Bergman S, et al. The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm. NeuroReport 1998;9:3253-3258.
7. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000;57:95-97.
8. Bench CJ, Friston KJ, Brown RG, Frackowiak RSJ, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993;23:579-590.
9. Bench CJ, Frackowiak RSJ, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995;25:247-251.
10. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex in schizophrenics. Arch Gen Psychiatry 1986;43:31-35.
11. Benes FM, Majocha R, Bird ED, Marotta CA. Increased vertical axon numbers in cingulated cortex of schizophrenics. Arch Gen Psychiatry 1987;44:1017-1021.
12. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABA-A receptor binding in superficial layers of cingulated cortex in schizophrenics. J Neurosci 1992;12:924-929.
13. Benes FM, Todtenkopf MS, Taylor JB. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulated cortex of schizophrenic brain. Synapse 1997;25:80-92.
14. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulated cortex of schizophrenic and bipolar subjects. Biol Psychiatry 2001;50:395-406.
15. Berger B. Comparative neurochemical analysis of the frontal cortex, with special emphasis on the dopamine innervation of the primary motor cortex, lateral prefrontal cortex, and anterior cingulated cortex. Chauvel P, Delgado-Escueta, editors. Advances in neurology, vol. 57. New York, NY: Raven, 1992. pp. 525-544.
16. Blackwood DH, Young AH, McQueen JK, et al. Magnetic resonance imaging in schizophrenia: altered brain morphology associated with P300 abnormalities and eye tracking dysfunction. Biol Psychiatry 1991;30:753-769.
17. Blennow K, Bogdanovic N, Gottfries C-G, Davidsson P. The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia. J Mol Neurosci 1999;13:101-109.
18. Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopoulos P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol 2001;102:373-379.
19. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Tress. Boca Raton: Chapman & Hall/CRC, 1993.
20. Brody AL, Saxena S, Silverman DHS, et al. Brain metabolic changes in major depressive disorder from pre-to post-treatment with paroxetine. Psychiatry Res: Neuro-imaging 1999;91:127-139.
21. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy. Arch Gen Psychiatry 2001;58:631-640.
22. Buchsbaum MS, Wu J, Siegel BV, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 1997;41:15-22.
23. 2O PET study during single-trial Stroop task performance. Am J Psychiatry 1999;156:803-804.
24. Carter CS, Mintun M, Nichols T, Cohen JD. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Am J Psychiatry 1997;154(12):1670-1675.
25. Cleghorn JM, Garnett ES, Nahmias C, et al. Regional brain metabolism during auditory hallucinations in chronic schizophrenia. Br J Psychiatry 1990;157:562-570.
26. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed., vol. 42. Hillsdale, NJ: Lawrence Erlbaum, 1998.
27. Conde F, Lund JS, Jacobowitz DM, Baimbridge KG, Lewis DA. Local circuit neurons immunoreactive for calretinin, calbinidn D-28k, or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol 1994;341:95-116.
28. Convit A, Wolf OT, de Leon MJ, et al. Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry Res 2001;107:61-73.
29. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulated cortex in major depressive disorder. Arch Gen Psychiatry 2001;58:545-553.
30. Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001;55a:585-595.
31. Damasio A, Van Hoesen G. Emotional disturbances associated with focal lesions of the limbic frontal lobe. In: Heilman K, Satz P, editors. Neuropsychology of human emotion, New York, NY: Guilford, 1983. pp. 85-110.
32. Davanzo P, Thomas MA, Yue K, et al. Decreased anterior cingulated myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001;24:359-369.
33. Davidsson P, Gottfries J, Bogdanovic N, et al. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res 1999;40:23-29.
34. Daviss SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbinidn-immunoreactive neurons. Psychiatry Res 1995;59:81-96.
35. De Asis JM, Stern E, Alexopoulos GS, et al. Hippocampal and anterior cingulate activation deficits in patients with geriatric depression. Am J Psychiatry 2001;158:1321-1323.
36. Delgado-Escueta AV, Swartz B, Maldonado H, Walsh R, Rand R, Halgren E. Complex partial seizures of frontal lobe origin. In: Wieser H, Elger C, editors. Presurgical evaluation of epileptics, Berlin: Springer, 1987. pp. 268-299.
37. Dolan RJ, Bench CJ, Brown RG, Scott LC, Friston KJ, Frackowiak RSJ. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry 1992;55:768-773.
38. Drevets WC, Price JL, Simpson JR, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-827.
39. Dolan RJ, Fletcher P, Frith CD, Friston KJ, Frackowiak RSJ, Grasby PM. Dopaminergic modulation of impaired cognitive activation in the anterior cingulated cortex in schizophrenia. Nature 1995;378:180-182.
40. Dwivedi Y, Pandey GN. Effect of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C and phosphoinositide-specific phospholipase C activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain. J Pharmacol Exp Ther 1999;291:688-704.
41. Eastwood SL, Cairns NJ, Harrison PJ. Synaptophysin gene expression in schizophrenia: investigations of synaptic pathology in the cerebral cortex. Br J Psychiatry 2000;176:236-242.
42. Eastwood SL, Harrison PJ. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 2001;55:569-578.
43. Erkwoh R, Sabri O, Steinmeyer EM, Bull U, Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatr Scand 1997;96:51-57.
44. Gabriel SM, Haroutunian V, Powchik P, et al. Increased concentrations of presynaptic proteins in the cingulated cortex of subjects with schizophrenia. Arch Gen Psychiatry 1997;54:559-566.
45. George MS, Ketter TA, Parekh PI, et al. Blunted left cingulated activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry 1997;9:55-63.
46. Goekjian PG, Jirousek MR. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors and agents in development. Curr Med Chem 1999;6:877-903.
47. Goldstein JM, Goodman JM, Seidman LJ, et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 1999;56:537-547.
48. Goodwin GM, Cavanagh JTO, Glabus MF, Kehoe RF, O'Carroll RE, Ebmeier KP. Uptake of 99m-Tc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: associations with mania. Br J Psychiatry 1997;170:426-430.
49. Haznedar MM, Buchsbaum MS, Luu C, et al. Decreased anterior cingulated gyrus metabolic rate in schizophrenia. Am J Psychiatry 1997;154:682-684.
50. Hirayasu Y, Shenton ME, Salisbury DF, et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999;156:1091-1093.
51. Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. Am J Psychiatry 2000;157:1634-1645.
52. Honer WG, Falkai P, Young C, et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 1997;78:99-110.
53. Jennings JM, McIntosh AR, Kapur S, Zipursky RB, Houle S. Functional network differences in schizophrenia: a rCBF study of semantic processing. NeuroReport 1998;9:1697-1700.
54. Kalus P, Senitz D, Beckmann H. Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients. Psychiatry Res 1997;75(1):49-59.
55. Kalus P, Senitz D, Lauer M, Beckmann H. Inhibitory cartridge synapses in the anterior cingulated cortex of schizophrenics. J Neural Transm 1999;106:763-771.
56. Kennedy SH, Evans KR, Kruger S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158:899-905.
57. Kiehl KA, Liddle PF. An event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia. Schizophr Res 2001;48:159-171.
58. Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001;55:651-659.
59. Knable MB, Barci BM, Bartko JJ, Webster MJ, Torrey EF. Molecular abnormalities in the major psychiatric illnesses: a classification and regression tree analysis of post-mortem prefrontal markers. Mol Psychiatry 2002;7:392-404.
60. Knable MB, Barci BB, Webster MJ, Torrey EF. Summary of prefrontal molecular abnormalities in the Stanley Foundation Neuropathology Consortium. In: Agam S, Everall IP, Belmaker RH, editors. The postmortem brain in psychiatric research, Boston, MA: Kluwer Academic Publishers, 2002.
61. Larisch R, Klimke A, Vosberg H, Loffler S, Gaebel W, Muller-Gartner H-W. In vivo evidence for the involvement of dopamine D2 receptors in striatum and anterior cingulated gyrus in major depression. Neuroimage 1997;5:251-260.
62. Lephart ED, Lund TD, Horvath TL. Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function. Brain Res Brain Res Rev 2001;37(1-3):25-37.
63. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ. Patterns of cerebral flow in schizophrenia. Br J Psychiatry 1992;160:179-186.
64. Manji HK, Chen G, Hsiao JK, Masana MI, Moore GJ, Potter WZ. Regulation of signal transduction pathways by mood stabilizing agents. In: Manji HK, Bowden CL, Belmaker RH, editors. Bipolar medications, mechanisms of action, Washington, DC: American Psychiatric Press, 2000. pp. 129-177.
65. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: a potential predictor of treatment response. NeuroReport 1997;8:1057-1061.
66. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-843.
67. Mesulam M-M. Patterns in behavioral neuroanatomy: association areas, the limbic system, and hemispheric specialization. In: Mesulam M-M, editor. Principles of behavioral neurology, Philadelphia, PA: Davis, 1985. pp. 1-70.
68. Mithani S, Atmadja S, Baimbridge KG, Fibiger HC. Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology 1987;93:94-100.
69. Moore CM, Breeze JL, Gruber SA, et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulated cortex. Bipolar Disord 2000;2:207-216.
70. Mulert C, Gallinat J, Pascual-Marqui R, et al. Reduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage 2001;13:589-600.
71. Nofziger EA, Berman S, Fasiczka A, et al. Effects of buproprion SR on anterior paralimbic function during wakefulness and REM sleep in depression: preliminary findings using 18F-FDG PET. Psychiatry Res: Neuro-imaging 2001;106:95-111.
72. Noga JT, Aylward E, Barta PE, Pearlson GD. Cingulate gyrus in schizophrenic patients and normal volunteers. Psychiatry Res: Neuro-imaging 1995;61:201-208.
73. Nohara S, Suzuki M, Kurachi M, et al. Neural correlates of memory organization deficits in schizophrenia: a single photon emission computed tomography study with 99mTc-ethyl-cysteinate dimmer during a verbal learning task. Schizophr Res 2000;42:209-222.
74. Nordahl TE, Kusubov N, Carter C, et al. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology 1996;15:541-554.
75. Nordahl TE, Carter CS, Salo RE, et al. Anterior cingulated metabolism correlates with Stroop errors in paranoid schizophrenia patients. Neuropsychopharmacology 2001;25:139-148.
76. Ohnuma T, Kmura M, Takahashi T, Iwamoto N, Arai H. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia. Psychiatry Clin Neurosci 1997;51:9-15.
77. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998;95:13290-13295.
78. Papez JW. A proposed mechanism of emotion. Arch Neurol Psychiatry 1937;38:725-743.
79. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2001;2:417-424.
80. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulated activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001;158:405-415.
81. Ragland JD, Gur RC, Raz J, et al. Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. Am J Psychiatry 2001;158:1114-1125.
82. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 1997;349:1735-1739.
83. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999;45:17-25.
84. Shergill SS, Brammer MJ, Williams SCR, Murray RM, McGuire PK. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 2000;57:1033-1038.
85. Siegel BV, Buchsbaum MS, Bunney WE, et al. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 1993;150:1325-1336.
86. Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Schizophr Res 1995;17:85-94.
87. Sigmundsson T, Suckling J, Maier M, et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenia patients with prominent negative symptoms. Am J Psychiatry 2001;158:234-243.
88. Spence SA, Brooks DJ, Hirsch SR, Liddle PF, Mechan J, Grasby PM. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain 1997;120:1997-2011.
89. Spence SA, Liddle PF, Stefan MD, et al. Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised. Br J Psychiatry 2000;176:52-60.
90. Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL. Structural brain abnormalities in first-episode mania. Biol Psychiatry 1993;33:602-609.
91. Szeszko PR, Bilder RM, Lencz T, et al. Reduced anterior cingulated gyrus volume correlates with executive dysfunction in men with first-episode schizophrenia. Schizophr Res 2000;43:97-108.
92. Takahashi M, Shirakawa O, Toyooka K, et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry 2000;5:293-300.
93. Tamminga CA, Thaker GK, Buchanan R, et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992;49:522-530.
94. Taylor SF, Tandon R, Koeppe RA. Global cerebral blood flow increase reveals focal hypoperfusion in schizophrenia. Neuropsychopharmacology 1999;21:368-371.
95. Thorns V, Licastro F, Masliah E. Locally reduced levels of acidic FGF lead to decreased expression of 28-kDa calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease. Neuropathology 2001;21:203-211.
96. Toone BK, Okocha CI, Sivakumar K, Syed GM. Changes in regional cerebral blood flow due to cognitive activation among patients with schizophrenia. Br J Psychiatry 2000;177:222-228.
97. Torrey EF, Webster M, Knable MB, Johnston N, Yolken RH. The Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophr Res 2000;44:151-155.
98. Wang YZ, Christakos S. Retinoic acid regulates the expression of the calcium binding protein, calbindin-D28K. Mol Endocrinol 1995;9:1510-1521.
99. Weinberger DR. A connectionist approach to the prefrontal cortex. J Neuropsychiatry 1993;5:241-253.